Recombinant viral antigens contain part of viral sequence meaning that the recombinant antigen contains a region which can be recognized by different antibodies produced by different individuals. This reduces the risk of false negatives which can occur with synthetic peptides, which contain only a small portion of the entire protein. If an individual infected with a viral antigen makes antibodies to a part of the protein not included in the synthetic peptides, a false negative results.

Recombinant viral protein usually contains a fusion protein/partner which produces superior attachment to assay surfaces such as wells. For this reason, smaller amounts of recombinant protein will produce the same results as larger amounts of unfused protein. The choice of fusion partner prevents false positives, allowing superior adhesion without incorrect results.

Applications include ELISA.  The ability to use these proteins ensure ELISAs are safe, specific and rapid. Even when a virus cannot be cultured, provided a gene sequence is available, it is possible to rapidly respond to emerging viruses and new viral strains of existing pathogens.

NameCatalog #TypeSpeciesApplicationsSizePrice
Apo Transferrin (ATF)PR27104-500ProteinH500 ug
1 gm
$275
$450
Cytomegalo Virus Pp28 (UL99)PR27124-100ProteinHWB; E100 ug
500 ug
$150
$600
Cytomegalo Virus MosaicPR27123-100ProteinHWB; E100 ug
500 ug
$150
$600
Rubella Virus E1 MosaicPR27125-100ProteinHWB; E100 ug
500 ug
$150
$600
Rubella Virus Capsid CPR27126-100ProteinHWB; E100 ug
500 ug
$150
$600
Herpes Simplex Virus-1 gGPR27128-100ProteinHWB; E100 ug
500 ug
$150
$600
Herpes Simplex Virus-1 gDPR27127-100ProteinHWB; E100 ug
500 ug
$150
$600
Herpes Simplex Virus-2 gDPR27129-100ProteinHWB; E100 ug
500 ug
$150
$600
Toxoplasma Gondii MIC 3PR27132-100ProteinHWB; E100 ug
500 ug
$150
$600